-
221
Effectiveness of Four-Decontamination Techniques on Bacterial Growth on CPR Manikins after Use in a CPR Course
Published 2017-08-01“…The American Red Cross and American Heart Association are strong advocates of preventing disease transmission during cardiopulmonary resuscitation (CPR) training by promoting careful and consistent manikin decontamination. …”
Get full text
Article -
222
-
223
-
224
Rotationplasty for Unplanned Fixation of Pathological Fracture Distal Femoral Osteosarcoma
Published 2020-01-01Get full text
Article -
225
-
226
The Association between Hepcidin and Iron Status in Children and Adolescents with Obesity
Published 2021-01-01Get full text
Article -
227
-
228
A Convolutional Neural Network Using Anterior Segment Photos for Infectious Keratitis Identification
Published 2025-01-01“…Vannarut Satitpitakul,1,2 Apiwit Puangsricharern,3 Surachet Yuktiratna,3 Yossapon Jaisarn,4 Keeratika Sangsao,4 Vilavun Puangsricharern,1,2 Ngamjit Kasetsuwan,1,2 Usanee Reinprayoon,1,2 Thanachaporn Kittipibul1,2 1Center of Excellence for Cornea and Stem Cell Transplantation, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 2Excellence Center for Cornea and Stem Cell Transplantation, Department of Ophthalmology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand; 3IM Impower Company Limited, Bangkok, Thailand; 4Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCorrespondence: Vannarut Satitpitakul, Department of Ophthalmology, King Chulalongkorn Memorial Hospital, 1873 Rama 4 Road, Pathumwan, Bangkok, 10330, Thailand, Tel +66-894959022, Email Vannarut.S@chula.ac.thPurpose: To develop a comprehensively deep learning algorithm to differentiate between bacterial keratitis, fungal keratitis, non-infectious corneal lesions, and normal corneas.Methods: This retrospective study collected slit-lamp photos of patients with bacterial keratitis, fungal keratitis, non-infectious corneal lesions, and normal cornea. …”
Get full text
Article -
229
-
230
-
231
-
232
The influence of the sinonasal microbiome on the development and management of rhinosinusitis
Published 2025-01-01Get full text
Article -
233
Availability, pricing, and affordability of antithrombotic medicines in Addis Ababa, Ethiopia: implications for health policy
Published 2025-01-01“…Five public hospital outpatient pharmacies, four private hospitals, ten private pharmacies, four Kenema pharmacies, and two Red Cross pharmacies in Addis Ababa, Ethiopia, were included in the study. …”
Get full text
Article -
234
-
235
A machine learning approach for predicting treatment response of hyponatremia
Published 2024-04-01Get full text
Article -
236
-
237
Different post-pancreatectomy glucagon responses to a meal test between surgical approaches
Published 2023-11-01Get full text
Article -
238
-
239
Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study
Published 2025-01-01“…Yoko Mizoguchi,1 Moeko Hino,2 Hitoshi Ueda,3 Yasuo Miyaguchi,3 Masao Kobayashi1,4 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; 2Department of Pediatrics, Chiba University Hospital, Chiba, Japan; 3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4Japanese Red Cross, Chugoku-Shikoku Block Blood Center, Hiroshima, JapanCorrespondence: Yasuo Miyaguchi, Japan Medical Office, Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan, Tel +81 70-4921-7966, Email yasuo.miyaguchi1@takeda.comPurpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. …”
Get full text
Article -
240